Passa al contenuto
Merck
  • Interleukin 10-Dominant Immune Response and Increased Risk of Cutaneous Leishmaniasis After Natural Exposure to Lutzomyia intermedia Sand Flies.

Interleukin 10-Dominant Immune Response and Increased Risk of Cutaneous Leishmaniasis After Natural Exposure to Lutzomyia intermedia Sand Flies.

The Journal of infectious diseases (2015-01-18)
Augusto M Carvalho, Juqueline R Cristal, Aline C Muniz, Lucas P Carvalho, Regis Gomes, José C Miranda, Aldina Barral, Edgar M Carvalho, Camila I de Oliveira
ABSTRACT

Leishmaniasis is caused by parasites transmitted to the vertebrate host by infected sand flies. During transmission, the vertebrate host is also inoculated with sand fly saliva, which exerts powerful immunomodulatory effects on the host's immune response. We conducted a prospective cohort analysis to characterize the human immune response to Lutzomyia intermedia saliva in 264 individuals, from an area for cutaneous leishmaniasis (CL) caused by Leishmania braziliensis. Antibodies were found in 150 individuals (56.8%); immunoglobulin G1 and G4 were the predominant subclasses. Recall responses to salivary gland sonicate showed elevated production of interleukin 10 (IL-10), interleukin 13, interferon γ, CXCL9, and CCL2 compared with controls. CD4(+)CD25(+) T cells, including Foxp3(+) cells, were the main source of IL-10. L. braziliensis replication was increased (P < .05) in macrophages cocultured with saliva-stimulated lymphocytes from exposed individuals and addition of anti-IL-10 reverted this effect. Positive correlation between antibody response to saliva and cellular response to Leishmania was not found. Importantly, individuals seropositive to saliva are 2.1 times more likely to develop CL (relative risk, 2.1; 95% confidence interval, 1.07-4.2; P < .05). Exposure to L. intermedia sand flies skews the human immune response, facilitating L. braziliensis survival in vitro, and increases the risk of developing CL.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Sigma-Aldrich
Substrato di fosfatasi, 5 mg tablets
Sigma-Aldrich
4-nitrofenil fosfato, suitable for enzyme immunoassay, ≥99.0% (enzymatic)
Sigma-Aldrich
Brefeldina A, from Penicillium brefeldianum, ≥99% (HPLC and TLC)
Sigma-Aldrich
4-nitrofenil fosfato, tablet
Sigma-Aldrich
Brefeldina A, ≥99% (HPLC and TLC), BioXtra, for molecular biology
Sigma-Aldrich
4-nitrofenil fosfato, powder, BioReagent, suitable for cell culture, ≥97%
Sigma-Aldrich
4-nitrofenil fosfato, tablet
Sigma-Aldrich
Substrato di fosfatasi, powder
Sigma-Aldrich
Brefeldina A, from Penicillium brefeldianum, Ready Made Solution, 10 mg/mL in DMSO
Sigma-Aldrich
Substrato di fosfatasi, 40 mg tablets
Sigma-Aldrich
4-nitrofenil fosfato, tablet
Sigma-Aldrich
Substrato di fosfatasi, 100 mg capsules
Sigma-Aldrich
Substrato di fosfatasi, 40 mg capsules
Sigma-Aldrich
Substrato di fosfatasi, Suitable for manufacturing of diagnostic kits and reagents